Search Results - "S N Avdeev"

Possibilities of ultrasound research of the diaphragm by Nekludova, G V, Avdeev, S N

“…The ultrasound method is a non-invasive and safe diagnostic method. Ultrasound examination (ultrasound) of the diaphragm allows you to conduct a direct study…”
Get full text

New opportunities of dual bronchodilation therapy for patients with chronic obstructive pulmonary disease by Avdeev, S N, Trushenko, N V

“…Currently, combinations of long-acting beta2-agonists and long-acting anticholinergics are considered as the basic therapy for majority of patients with…”
Get full text

The new endothelin receptor antagonist macitentan: Prospects for therapy of pulmonary arterial hypertension by Avdeev, S N

“…Pulmonary arterial hypertension (PAH) is a clinical group of severe and rare diseases with similar morphological, hemodynamic, and therapeutic characteristics…”
Get full text

Systemic inflammation in patients with chronic obstructive pulmonary disease and obesity by Ovsyannikov, E. S., Avdeev, S. N., Budnevsky, A. V.

“…Chronic obstructive pulmonary disease (COPD) is an important public health problem. According to various studies, the prevalence of obesity in patients with…”
Get full text

Clinical efficacy of mechanical bacterial lysate in the prevention of infectious exacerbations of chronic obstructive pulmonary disease by Avdeev, S. N., Nuralieva, G. S., Gainitdinova, V. V., Baimakanova, G. E., So, A. K., Merzhoeva, Z. M.

“…Aim. To evaluate the efficacy of mechanical bacterial lysate on the prevention of infectious exacerbations of chronic obstructive pulmonary disease in patients…”
Get full text

Approaches to therapy for pulmonary hypertension: Role of the endothelin receptor antagonist bosentan by Avdeev, S N

“…Pulmonary hypertension (PH) is a specific clinical group of severe and rare diseases with similar morphological, hemodynamic, and therapeutic characteristics…”
Get full text

Combination therapy is a new standard for treatment of pulmonary arterial hypertension by Avdeev, S N, TsarEva, N A, Gaisin, I R

“…At present, compelling evidence has been obtained that combined therapy of pulmonary arterial hypertension (PAH) with specific drugs can significantly slow…”
Get full text

Eosinophilic inflammation in chronic obstructive pulmonary disease by Avdeev, S N, Trushenko, N V, Merzhoeva, Z M, Ivanova, M S, Kusraeva, E V

“…Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease that combines various clinical manifestations and pathophysiological mechanisms. It…”
Get full text

Clinical and economic comparison of utilization of reslizumab, mepolizumab and benralizumab in the treatment of severe eosinophilic asthma by Zyryanov, S K, Avdeev, S N, Ivanov, D A, Zhuravleva, M V, Kniajeskaia, N P, Matveev, N V, Nenasheva, N A, Fomina, D S, Frolov, M I

“…During last few years, the approaches to the management of patients with severe asthma have been revised. Monoclonal antibodies (MABs), inhibitors of…”
Get full text

Choice of novel endpoints in clinical trials evaluating the efficiency of drug therapy in patients with pulmonary hypertension by Avdeev, S N

“…Pulmonary hypertension (PH) is characterized by a poor prognosis: the three-year survival rate in patients with PH is not greater than 60% as evidenced by…”
Get full text

A patient with severe idiopathic pulmonary arterial hypertension: Is there a way out? by N A Tsareva, S N Avdeev, G V Neklyudova

“…The paper considers a clinical example of current therapy for idiopathic pulmonary arterial hypertension in a female patient with its clinical deterioration…”
Get full text

Clinical and economic analysis of Reslizumab use in the treatment of patients with severe allergic eosinophilic asthma by Kolbin, A S, Avdeev, S N, Zhuravleva, M V, Gomon, Yu M, Balykina, Yu E, Matveyev, N V, Proskurin, M A, Fedosenko, S V

“…Asthma is a heterogeneous chronic disease of airways. One of its endotypes is eosinophilic asthma, accompanied by both peripheral blood and airway…”
Get full text

The concept of chronic obstructive pulmonary disease clinical control as a decision - making tool in real clinical practice for optimizing of basic pharmacotherapy by Avdeev, S N, Aisanov, Z R, Belevsky, A S, Beeh, K M, Vizel, A A, Zyryanov, S K, Ignatova, G L, Kostikas, K, Leshchenko, I V, Ovcharenko, S I, Sinopal’nikov, A I, Titova, O N, Shmelev, E I

“…The main goals of COPD therapy are to achieve clinical stability with minimal clinical manifestations and low risk of relapse. The proposed COPD control…”
Get full text

Severe bronchial asthma patient care organization in various regions of the Russian Federation. From endotypes and phenotypes of bronchial asthma to personalized choice of therapy by Avdeev, S. N., Volkova, O. A., Demko, I. V., Ignatova, G. L., Leshchenko, I. V., Kanukova, N. A., Kudelya, L. M., Nevzorova, V. A., Nedashkovskaya, N. G., Ukhanova, O. P., Shulzhenko, L. V., Fassakhov, R. S.

“…The meeting of the Expert board was held in Moscow on June 24, 2019, at which the following issues were considered: the applicability of a new terminology…”
Get full text

Treatment of exacerbations of chronic obstructive pulmonary disease by Avdeev, S N, Truschenko, N V, Gaynitdinova, V V, Soe, A K, Nuralieva, G S

“…To assess the quality of medical care provided in large Russian hospitals to patients with COPD exacerbation. The study included patients with acute…”
Get full text

Risk factors for the early development of septic shock in patients with severe COVID-19 by Glybochko, P V, Fomin, V V, Moiseev, S V, Avdeev, S N, Yavorovskiy, A G, Brovko, M Y, Umbetova, K T, Aliev, V A, Bulanova, E L, Bondarenko, I B, Volkova, O S, Gaynitdinova, V V, Gneusheva, T Y, Dubrovin, K V, Kapustina, V A, Kraeva, V V, Merzhoeva, Z M, Nuralieva, G S, Nogtev, P V, Panasyuk, V V, Politov, M E, Popov, A M, Popova, E N, Raspopina, N A, Royuk, V V, Sorokin, Y D, Trushenko, N V, Khalikova, E Y, Tsareva, N A, Chikina, S Y, Chichkova, N V, Akulkina, L A, Bulanov, N M, Ermolova, L A, Zykova, A S, Kitbalyan, A A, Moiseev, A S, Potapov, P P, Tao, E A, Sholomova, V I, Shchepalina, A A, Yakovleva, A A

“…In a retrospective study, we evaluated factors associated with the early development of septic shock in patients with severe COVID-19. We collected medical…”
Get full text

COVID-19: Opportunities to Improve Prognosis by Avdeev, S. N.

“…COVID-19 is characterized by a severe course in approximately 5‒10% of patients, who require admittance to the intensive care unit and mechanical ventilation,…”
Get full text

Clinical guidelines for the diagnosis and treatment of pulmonary hypertension by Chazova, I E, Avdeev, S N, Tsareva, N A, Volkov, A V, Martyniuk, T V, Nakonechnikov, S N

“…Pulmonary hypertension (PH) is a group of diseases characterized by progressive increases in pulmonary vascular resistance and pulmonary artery pressure, which…”
Get full text

PATHOLOGIC PHYSIOLOGY OF EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE by Avdeev, S. N.

“…The lecture describes the mechanisms of deterioration of respiratory exchange during exacerbation of chronic obstructive pulmonary disease (COPD). It has been…”
Get full text

First clinical experience with endothelin receptor antagonist bosentan used in patients with pulmonary hypertension: results of a one-year study by Avdeev, S N, tsareva, N A, Nekliudova, G V, Chuchalin, A G

“…To evaluate the efficiency and safety of long-term (12-month) treatment with the endothelin receptor antagonist bosentan (tracleer (Actelion, Switzerland)) in…”
Get full text